Lind I
WHO Collaborating Centre for Reference and Research in Gonococci, Neisseria Department, Statens Seruminstitut, Copenhagen, Denmark.
Clin Infect Dis. 1997 Jan;24 Suppl 1:S93-7. doi: 10.1093/clinids/24.supplement_1.s93.
The changing patterns of antimicrobial resistance in Neisseria gonorrhoeae have been reviewed regularly since the introduction of antimicrobial therapy in the 1930s. At present, ceftriaxone, fluoroquinolones, and spectinomycin have remained efficient as single-dose treatment of gonorrhea worldwide. To ensure that limited resources can be used in the best possible way, continuous surveillance of gonococcal resistance to antimicrobials is needed.
自20世纪30年代引入抗菌治疗以来，淋病奈瑟菌的抗菌耐药模式变化情况一直受到定期审查。目前，头孢曲松、氟喹诺酮类药物和大观霉素在全球范围内仍是治疗淋病的单剂量有效药物。为确保有限的资源能够得到最合理的利用，需要持续监测淋球菌对抗菌药物的耐药情况。
